, Thailand

Bumrungrad International Hospital creates first digital microbiology laboratories.

This includes the digitization of its core laboratory, handling 60-70% of its annual tests.

Bumrungrad International Hospital has created Thailand's first fully digital microbiology laboratories, according to an announcement. The deployment includes the digitization of Bumrungrad’s core laboratory, which handles 60-70% of the hospital’s five million annual tests on around one million samples.

Currently, very few microbiology labs have fully digitized their operations due to workflow complexity and lack of electronic medical record (EMR) systems that support end-to-end lab processes or integrated workflows used in microbiology labs.

The hospital has been using InterSystems’ TrakCare® Lab Enterprise, which integrates patient data within the EMR for improved clinical support and patient-centered workflows, and captures comprehensive operational data.

The digitization follows Bumrungrad’s go-live with the InterSystems TrakCare unified healthcare information system in October 2018 to support world-class care delivery throughout the hospital.

As a core function, microbiology labs culture and identify microbes and test their susceptibility to antibiotics to establish the best treatments for patients. To digitize this process, Bumrungrad created a decision tree to map its microbiology workflows and TrakCare Lab Enterprise was configured to support them.

The product’s interoperability capabilities were also used to integrate with the BD EpiCenter™ microbial identification and VITEK® antibiotic susceptibility systems via standard HL7 messaging. TrakCare Lab Enterprise now digitally manages the entire end-to-end testing process.

“The primary outcome is improved service delivery—making it easier for clinicians to deliver care, having confidence in the results with no transcription errors, and reporting results in a much more timely way,” said Jeremy Ford, Laboratory Research and Technology Director for Bumrungrad.

Bumrungrad said it will roll out further enhancements to TrakCare Lab Enterprise in its surgical pathology and referral laboratories later this year, with the blood bank following in early 2021, making all lab processes fully digital and paperless.

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox
It was recognised for its cutting-edge medical device packaging design, Dispenser Integrated System Kit (DISK).
There has been an expanding research base across India, China, and Japan.
It combines third-party assured data verification with blockchain technology.
Consultation is available for only $0.014 (INR1).
The number of hospitals operating on hip fracture that have access to a fracture liaison service has been steadily rising from 2013 to 2020.
GMT Manila’s award-winning initiative, in collaboration with Endec Inc. and Scilore LLC, is a rapidly deployable turnkey solution for RT-PCR Testing that made it more available across the Philippines. 
As The National Cardiovascular Referral Center in Indonesia, NCCHK has been acknowledged by Asia's Healthcare Industry.
Currently, North America dominates the market across the globe.
More medical devices are being bought for home use.
It has also introduced a new hotline service.
The firm was recognised for its multiple initiatives in braving the COVID-19 crisis.
It took home the Training Initiative of the Year trophy for its non-invasive therapy treatment for benign prostatic hyperplasia (BPH).
The country’s SII makes up about half of Covax supply.
It owns 39 hospitals and eight clinics across England, Wales, and Scotland.
The company plans to set up over 100 in-school clinics.